U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156601156601Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart FailureTerminatedNo Results AvailableCongestive Heart FailureDevice: Cardiac Compass with OptiVol Fluid Status Monitoringhttps://ClinicalTrials.gov/show/NCT00510198
156602156602Early Aggressive Versus Initially Conservative Therapy in Elderly Patients With Non-ST-Elevation Acute Coronary SyndromeCompletedNo Results AvailableAcute Coronary SyndromeOther: systematic coronary intervention|Other: coronary intervention only for cases refractory to medical therapyhttps://ClinicalTrials.gov/show/NCT00510185
156603156603Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2RecruitingNo Results AvailableHeadache|Migraine|VasodilatationDrug: Prostacyclin, PGI2|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00510172
156604156604Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating SchistosomiasisCompletedNo Results AvailableSchistosoma HaematobiumDrug: Artesunate+Sulfamethoxypyrazine/pyrimethamin|Drug: Praziquantelhttps://ClinicalTrials.gov/show/NCT00510159
156605156605Olanzapine Treatment of Patients With Bipolar I DisorderCompletedHas ResultsDepression, BipolarDrug: Olanzapine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00510146
156606156606A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)CompletedNo Results AvailableAcute Myelogenous LeukemiaBiological: GRNVAC1https://ClinicalTrials.gov/show/NCT00510133
156607156607Comparison of Two Psychosocial Therapies for Treating Children With Oppositional-Defiant DisorderCompletedNo Results AvailableOppositional-Defiant DisorderBehavioral: Parent management training (PMT)|Behavioral: Collaborative problem solving (CPS)|Behavioral: Waitlist controlhttps://ClinicalTrials.gov/show/NCT00510120
156608156608Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGCRecruitingNo Results AvailableStomach Neoplasm|Stage IV|RecurrentDrug: oxaliplatin|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00510107
156609156609Effectiveness of Treatment for Relational Aggression in Urban African American GirlsCompletedNo Results AvailableAggressionBehavioral: Friend to Friend program|Behavioral: Psychoeducational attention control interventionhttps://ClinicalTrials.gov/show/NCT00510094
156610156610An Evaluation of an Injectable Material for Correction of WrinklesWithdrawnNo Results AvailableJowlsDevice: Calcium Hydroxylapatite injectionhttps://ClinicalTrials.gov/show/NCT00510081
156611156611Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine TumorsCompletedHas ResultsAdvanced Neuroendocrine Tumors of Pancreatic OriginDrug: Everolimus|Drug: Everolimus Placebohttps://ClinicalTrials.gov/show/NCT00510068
156612156612Treatment of Acne Scarring With a Novel Procedure CombinationCompletedNo Results AvailableAcne ScarringProcedure: subdermal manipulation ONLY|Procedure: subdermal manipulation AND injection of a fillerhttps://ClinicalTrials.gov/show/NCT00510055
156613156613National Study of Moderate and Severe Von Willebrand Disease in the NetherlandsCompletedNo Results AvailableVon Willebrand Diseasehttps://ClinicalTrials.gov/show/NCT00510042
156614156614Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered IntravenouslyCompletedNo Results AvailableArrhythmiaDrug: GAP-134https://ClinicalTrials.gov/show/NCT00510029
156615156615Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence SyndromeCompletedNo Results AvailableNeonatal Abstinence SyndromeDrug: Clonidine HCLhttps://ClinicalTrials.gov/show/NCT00510016
156616156616Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldCompletedNo Results AvailableAtopic DermatitisDrug: Pimecrolimushttps://ClinicalTrials.gov/show/NCT00510003
156617156617Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingCompletedNo Results AvailableAtopic DermatitisDrug: Pimecrolimushttps://ClinicalTrials.gov/show/NCT00509990
156618156618Study of Light Treatment and Laser Treatment for MelasmaCompletedNo Results AvailableMelasmaProcedure: Light Treatment|Procedure: Laser Treatmenthttps://ClinicalTrials.gov/show/NCT00509977
156619156619Second-Line Irinotecan vs. ILF for AGCRecruitingNo Results AvailableStomach Neoplasm|Metastatic|Second-LineDrug: irinotecan|Drug: ILFhttps://ClinicalTrials.gov/show/NCT00509964
156620156620Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific PhobiasCompletedNo Results AvailableAnxiety Disorders|Specific PhobiaBehavioral: One-session exposure treatment|Behavioral: Augmented one-session exposure treatmenthttps://ClinicalTrials.gov/show/NCT00509951
156621156621Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant RecipientsCompletedNo Results AvailableHematopoietic Stem Cell Transplantation|Bacterial Infections and MycosesDrug: human lactoferrin peptide 1-11https://ClinicalTrials.gov/show/NCT00509938
156622156622Effect of Insulin Detemir on Use of Energy in Type 1 DiabetesTerminatedHas ResultsDiabetes|Diabetes Mellitus, Type 1Drug: insulin detemir|Drug: insulin NPH|Drug: insulin asparthttps://ClinicalTrials.gov/show/NCT00509925
156623156623Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia MyelofibrosisActive, not recruitingHas ResultsMyelofibrosis|Polycythemia Vera|ThrombocytosisDrug: Ruxolitinibhttps://ClinicalTrials.gov/show/NCT00509899
156624156624Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of SweatingCompletedNo Results AvailableHyperhidrosis|Excess SweatingDrug: Drysol|Drug: Drioffhttps://ClinicalTrials.gov/show/NCT00509886
156625156625A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedHas ResultsBacterial ConjunctivitisDrug: Gatifloxacin 0.5% eye drops|Drug: placebo eye dropshttps://ClinicalTrials.gov/show/NCT00509873
156626156626Irinotecan (Camptosar) in Patients With Advanced SarcomasCompletedNo Results AvailableSarcomaDrug: Irinotecanhttps://ClinicalTrials.gov/show/NCT00509860
156627156627A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. EpidermidisWithdrawnNo Results AvailableStaphylococcal Infections|BacteremiaDrug: human lactoferrin peptide 1-11https://ClinicalTrials.gov/show/NCT00509847
156628156628A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven CandidaemiaWithdrawnNo Results AvailableCandidaemiaDrug: hLF1-11|Drug: hLF1-11|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00509834
156629156629Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Patients With Newly Diagnosed GlioblastomaActive, not recruitingNo Results AvailableGlioblastoma MultiformeDrug: enzastaurin|Radiation: radiationhttps://ClinicalTrials.gov/show/NCT00509821
156630156630Evaluation of an Electro-stimulator for the Treatment of XerostomiaCompletedNo Results AvailableXerostomiaDevice: Electrostimulationhttps://ClinicalTrials.gov/show/NCT00509808

* Görseller ve İçerik tekif hakkına sahip olabilir